We propose that a magnified combined effect of GAS5, miR-146a, IRAK-1, and miR-155 genetic variants via epistatic interactions might impact the risk of MS and its phenotypes and could help in the risk stratification of MS patients. Here, IRAK1 is linked to myeloid sarcoma.